- Published on:
Havana, Jan 16 (Prensa Latina) Cuba's Finlay Vaccine Institute (IFV) announced the start of the phase II-III clinical trial with Neumo 11, an 11-valent anti-pneumococcal conjugate vaccine candidate, for adults aged 50 to 74, it was revealed today.